Literature DB >> 15704049

Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study.

Amit K Gupta1, L Joseph Melton, Gloria M Petersen, Lawrence J Timmons, Santhi Swaroop Vege, William S Harmsen, Nancy N Diehl, Alan R Zinsmeister, David A Ahlquist.   

Abstract

BACKGROUND & AIMS: Colorectal cancer (CRC) screening has been advocated increasingly during the past 2 decades, but there is little direct evidence that it has affected cancer incidence or presentation at the population level. This study assessed concurrent trends in CRC incidence, presentation, survival, mortality, and polypectomies in Olmsted County, Minnesota.
METHODS: Longitudinal observational study was conducted of all Olmsted County residents with colorectal adenocarcinoma first diagnosed in 1980-1999.
RESULTS: Altogether, 889 invasive CRCs were diagnosed among Olmsted County residents from 1980 through 1999. Annual age- and sex-adjusted CRC incidence rates decreased significantly during this period (P = .02) with a 23% decline from 60 per 100,000 in 1980-1984 to 46 per 100,000 in 1995-1999. This was primarily accounted for by a 40% reduction in left-sided CRC (P < .001). The incidence of right-sided CRC remained unchanged, but the proportion of right-sided CRC increased from 46% to 58%. Cancer stage shifted downward, and survival improved over time. The overall proportion of screen-detected CRC rose from 8% to 17%. Annual adjusted adenomatous polypectomy rates increased dramatically from 86 to 320 per 100,000 (P < .001).
CONCLUSIONS: The incidence of CRC in Olmsted County has declined in recent years. An impact of screening is suggested by the observed upward trend in screen-detected cases, a favorable stage shift, and a concurrent rise in polypectomy rates. However, the incidence of right-sided cancer remains unaltered and might be less affected by historically used screening interventions. Most CRCs still present symptomatically, and more effective population screening is needed.

Entities:  

Mesh:

Year:  2005        PMID: 15704049     DOI: 10.1016/s1542-3565(04)00664-0

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  33 in total

1.  [Laser ablation. Do we still need it?].

Authors:  C Rosenberg; C O M Hoffmann; B Mensel; R Puls; N Hosten
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

2.  Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.

Authors:  David A Ahlquist; Hongzhi Zou; Michael Domanico; Douglas W Mahoney; Tracy C Yab; William R Taylor; Malinda L Butz; Stephen N Thibodeau; Linda Rabeneck; Lawrence F Paszat; Kenneth W Kinzler; Bert Vogelstein; Niels Chr Bjerregaard; Søren Laurberg; Henrik Toft Sørensen; Barry M Berger; Graham P Lidgard
Journal:  Gastroenterology       Date:  2011-11-04       Impact factor: 22.682

3.  Early detection of colon cancer-the kaiser permanente northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients?

Authors:  David Moiel; John Thompson
Journal:  Perm J       Date:  2011

4.  Role of Endoscopic Resection Versus Surgical Resection in Management of Malignant Colon Polyps: a National Cancer Database Analysis.

Authors:  Dhruv Lowe; Sheikh Saleem; Muhammad Osman Arif; Shreya Sinha; Gary Brooks
Journal:  J Gastrointest Surg       Date:  2019-08-19       Impact factor: 3.452

5.  Black Patients with Colorectal Cancer Have More Advanced Cancer Stage at Time of Diagnosis: A Community-Based Safety-Net Hospital Experience.

Authors:  Chuck Chan; Aristeo Lopez; Garland Castaneda; Taft Bhuket; Benny Liu; Stephen Yee; David Irwin; Robert J Wong
Journal:  J Community Health       Date:  2017-08

6.  Correlation between preoperative endoscopic and intraoperative findings in localizing colorectal lesions.

Authors:  Martine Adam Louis; Kalyana Nandipati; Rakel Astorga; Anupa Mandava; Carl-P Rousseau; Neil Mandava
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

Review 7.  Molecular markers for colorectal cancer screening.

Authors:  Brandon T Dickinson; John Kisiel; David A Ahlquist; William M Grady
Journal:  Gut       Date:  2015-05-20       Impact factor: 23.059

8.  Risk Factors for Lymph Node Metastasis in Pathological T1b Colorectal Cancer.

Authors:  Atsushi Naito; Kazuya Iwamoto; Masahisa Ohtsuka; Mitsunobu Imasato; Yujiro Nakahara; Manabu Mikamori; Kenta Furukawa; Jeongho Moon; Tadafumi Asaoka; Kentaro Kishi; Hiroki Akamatsu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy.

Authors:  Mitchell D Wong; Susan L Ettner; W John Boscardin; Martin F Shapiro
Journal:  J Gen Intern Med       Date:  2009-02-03       Impact factor: 5.128

Review 10.  Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly.

Authors:  Peter R Holt; Peter Kozuch; Seetal Mewar
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.